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Abstract Prostate stromal cells may play binary roles in
the process of prostate cancer development. As the first to
be encountered by infiltrating prostate cancer cells, prostate
stromal cells form the first defense line against prostate
cancer progression and metastasis. However, interaction
between prostate cancer and stromal cells may facilitate the
formation of a tumor microenvironment favoring cancer
cell growth and survival. To establish an experimental
system for studying the interaction between cancer and
stromal cells, we isolated three matched pairs of normal and
cancer-associated human prostate stromal clones. In this
report, we describe the morphologic and behavioral
characteristics of these cells and their effect on LNCaP
prostate cancer cells in co-culture. Unlike LNCaP prostate
cancer cells, the isolated prostate stromal clones are large
fibroblast-like cells with a slow proliferation rate. Growth
and survival of these clones are not affected by androgens.
The stromal cells display high resistance to serum starva-
tion, while cancer-associated stromal clones have differen-
tiated survival ability. In co-culture experiments, the
stromal cells protected some LNCaP prostate cancer cells
from death by serum starvation, and cancer-associated
stromal clones showed more protection. This work thus
established a panel of valuable human prostate stromal cell
lines, which could be used in co-culture to study the
interaction between prostate cancer and prostate stromal
cells.
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Introduction
The prostate stroma is involved in prostate oncogenesis and
prostate cancer progression (Chung 1995; Harding and
Theodorescu 2000; Sung and Chung 2002; Condon 2005;
Loberg et al. 2005). Completely embedding the epithelial
glandular branches, the prostate stroma is predictably the
first zone encountered by cancer cells breaking away from
the epithelial layer. Whether the stromal compartment
inhibits or promotes prostate cancer progression would
have a deep impact on the entire process of the disease.
The stromal compartment is an integral part of the
functional prostate. During embryonic development, the
stromal cells direct budding and ductal branching morpho-
genesis (Chung and Cunha 1983; Cunha 1994; Cunha et al.
1995, 2004). In tissue reconstitution studies, embryonic
stromal cells determine the fate of the epithelial differen-
tiation (Chung and Cunha 1983; Cunha 1994; Chung 1995;
Cunha et al. 1995, 2002, 2004). Mechanistically, it is
suggested that prostate stromal cells respond to sex
hormones by producing andromedins, soluble factors
mediating growth, and differentiation of the epithelial
compartment (Yan et al. 1992; Fasciana et al. 1996; Lu et
al. 1999; Planz et al. 1999). In prostate cancer, the
functional characteristics of the prostate stroma could be
hijacked by cancer cells to form a favorable tumor
microenvironment. We have demonstrated that stromal
cells in the tumor microenvironment play an important role
in determining the fate of cancer cells. Through chimeric
tumor formation with MS osteosarcoma cells, for instance,
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androgen-dependent and non-tumorigenic LNCaP prostate
cancer cells can be converted to the androgen-independent
and tumorigenic C4-2 subline (Gleave et al. 1991; Wu et al.
1994). Similar changes were observed in LNCaP cells after
being co-cultured with MG63 osteosarcoma cells (Rhee et
al. 2001). In addition, by xenograft tumor formation and
metastasis, the epithelial cell-like ARCaPE prostate cancer
cells could be changed into mesenchymal stroma-like cells
displaying increased tumorigenicity and metastatic potency
(Xu et al. 2006; He et al. 2009). These studies established
that interaction with stromal cells is a critical step for cancer
cells to acquire additional malignant potential during
prostate cancer progression and metastasis.
It should be pointed out that many studies on cancer–
stromal interaction take osteosarcoma or immortalized
stromal cells as surrogates for mesenchymal stromal cells.
Xenograft tumor formation in athymic mice may not be
easily adapted to mechanistic studies of cancer–stromal
interaction. Although prostate stromal cells are suspected as
a culprit in prostate oncogenesis, there is little direct
evidence pinpointing a causal role for these cells, and the
pathologic relevance of stromal cells to prostate cancer
remains to be confirmed. A major hindrance to the study of
prostate stromal cells is the lack of an experimental system
in which well-characterized stromal cells can be studied in
a reproducible fashion, and their role examined by
simulating the interaction between cancer and stromal cells.
We have established three matched pairs of normal and
cancer-associated human prostate stromal cell lines to
facilitate the study of cancer–stromal interaction. In this
report, we outline the isolation and initial characterization
of these cell lines. Their role in promoting prostate cancer
progression is exemplified by a study of cancer–stromal
interaction in a co-culture of prostate cancer and stromal
cells.
Materials and Methods
Human prostate cancer cell lines. Unless specified, all the
cells used in this study were maintained in T-medium
(Invitrogen, Carlsbad, CA) containing 10% fetal bovine
serum (FBS, Atlanta Biologicals, Lawrenceville, GA),
penicillin (100 U/ml), and streptomycin (100 μg/ml) at
37°C, in humidified atmospheric air supplemented with 5%
CO2. The human prostate cancer cell line LNCaP used was
a kind gift of Dr. Gary Miller (University of Colorado,
Denver, CO) (Gleave et al. 1991). For this study, cells
between original passages 29 and 34 were used.
Cloning prostate stromal cells from clinical specimens.
Three matched pairs of normal and cancer-associated
prostate specimens were obtained under an IRB protocol.
The specimens were from three prostate cancer patients
who underwent radical prostatectomy in the Department of
Urology, Emory University School of Medicine. No
identifier or disease history was provided, but the tumor
in these prostates was confirmed by histopathologic
diagnosis. To obtain a normal prostate specimen, a cube
(<150 mm3) of prostate tissue was dissected by a
pathologist from a histologically normal region distal to
the tumor. Another cube was dissected from a cancer-
affected zone from the same prostate to provide a matched
cancer specimen.
Upon arrival at the laboratory, the specimens were diced
with a sterile razor blade. The sample was incubated at
37°C for 1 h in phosphate-buffered saline (PBS) containing
2.4 units of Dispase II (Roche Diagnostics, Indianapolis,
IN). After washing in PBS, live cells were plated in low
density (1×105) onto a 15-cm culture dish for 2 wk.
Epithelial cells with low attachment to plastic surface were
collected in the medium for further characterization. The
culture dish was rinsed three times before picking stromal
colonies, which were tightly attached to the dish. For each
specimen, 12 colonies were picked with cloning disk and
amplified. A representative clone was used in this study.
For comparison, PrSC, a primary normal human prostate
stromal cell line, was purchased from Lonza Walkersville,
Inc. (Walkersville, MD). PrSC cells between passages 6 and
11 cultured in T medium were used.
Serum starvation and androgen deprivation. Cells (2×105/
well) were plated onto six-well plates. After 24 h for
attachment, the culture was rinsed with PBS to remove
serum. Serum starvation was carried out by culturing cells
with serum-starvation medium, which was phenol red-free
RPMI 1640 medium (Invitrogen) containing no FBS. To
perform androgen deprivation, cells were cultured first in
serum-starvation medium for 48 h to exhaust androgens and
then in androgen-deprivation medium, which was phenol
red-free RPMI 1640 medium containing 1% charcoal/
dextran stripped FBS (Hyclone, Logan, UT).
Androgen stimulation and measurement of PSA. Cells on
six-well plates at 75% confluence were first subjected to
48-h serum starvation and then treated with 5 nM of
synthetic androgen methyltrienolone (R1881, Perkin Elmer,
Waltham, MA) in the androgen-deprivation medium.
Culture medium was collected for measuring prostate-
specific antigen (PSA) concentration with commercial
PSA ELISA kits (United Biotech Inc., Mountain View,
CA). Triplicate assays were performed on each sample.
Transfection. The protocol for transfecting prostate cancer
cells with linearized pAsRed2 eukaryotic expression vector
was previously reported (He et al. 2009). In this study,
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LNCaP cells were used in transfection. G418 (300 μg/ml)
was used to select for stably transfected cells, which were
cloned subsequently by the method of limited dilution. RL-1,
a selected LNCaP clone stably expressing the AsRed2 red
fluorescence protein, was used in this study.
Cancer–stromal co-culture. Prostate stromal cells were
grown in six-well plates with 2 ml culture medium in each
well. The cells were allowed to grow to full confluence.
After removing culture medium from the stromal cells,
prostate cancer LNCaP cells in low density (5×104/ml) in
4 ml fresh medium were overlaid onto the stromal
monolayer. The volume of the medium in co-culture was
always double the volume used when each cell type was
cultured alone.
Cell proliferation assay. Crystal violet staining was used to
determine the growth rate using our published protocol (Xu
et al. 2006). In this study, cells from each stromal cell line
were plated in low density (1×104/well) onto 24-well plates
in triplicate wells. The culture was terminated 4 d later,
before any of the cell lines reached confluence. Following
crystal violet staining, relative growth rate was determined
by spectrophotometric reading at OD595.
Colony formation assay. Cells in six-well plates were
subjected to serum starvation in triplicate for 60 d. The
cells in each well were then collected as single-cell
suspension and plated onto a 15-cm dish. After cultured
in T medium containing 10% FBS for 2 wk, colonies in
each dish were counted. To assay colony formation of co-
cultured cancer and stromal cells, red fluorescence micros-
copy was used to distinguish colonies of the red fluorescent
prostate cancer cells from colonies of stromal cells.
Microphotography. The equipment and software used in
phase contrast and fluorescence microphotography was
reported previously (Xu et al. 2006; He et al. 2009). Cell
size was determined with the Image-Pro Plus software,
which was calibrated with a micrometer.
Statistical analysis. Student’s t test was used. Level of
statistical significance between control and treated groups
was set at P<0.05.
Results
Establishment of matched pairs of human prostate stromal
cell lines. We obtained three matched pairs of normal and
cancer-associated human prostate specimens. After the
specimens were disintegrated into single-cell preparations,
cells in each preparation were plated in low density and
cultured for colony formation. From each ex vivo culture,
12 stromal cell-like colonies tightly attached to the culture
dish were picked and amplified as individual clones. By
inspection during the first three passages, we found that all
clones from each specimen had a similar cellular morphol-
ogy and growth rate. A representative clone from each
specimen was used for further investigation.
Using this protocol, we established three matched pairs
of human prostate stromal cell clones. These clones were
named as human prostate stromal (HPS) cells, with a
numerical affix reflecting the chronological order of the
isolation. These paired clones are HPS-10 (normal) and
HPS-11 (cancer-associated), HPS-12 (normal) and HPS-13
(cancer-associated), and HPS-14 (normal) and HPS-15
(cancer-associated).
Characteristics of the prostate stromal cell clones. On
microscopic inspection, the most prominent feature of the
prostate stromal clones is their expanded cell size. Whereas
the PrSC normal prostate stromal fibroblast cells are large,
the HPS clones all showed even larger cell sizes (Fig. 1). At
sub-confluence, an average HPS cell measured 300×50 μm
at the largest dimensions. On the other hand, the HPS cells
were flatter than cancer cells, yielding less refraction during
phase contrast microscopy.
The normal and cancer-associated stromal counterparts
shared cellular morphology and size, but each matched pair
could be different from the other pairs (Fig. 1). This is
especially obvious for the pair of HPS-12 and HPS-13.
Both the normal HPS-12 and the cancer-associated HPS-13
stromal cells shared an expanded and flat shape, almost
indistinguishable from each other. On the other hand, this
pair of cells could be easily distinguished from other
matched pairs.
We tested whether cells of the HPS clones could endure
prolonged culture without entering senescence. Using a
quarter of the first 1×106 cells as passage 1, we cultured the
matched pairs for 60 passages, with a 1:3 subculture ratio.
Whereas changes in growth rate were minimal during the
first 30 passages, proliferation of the HPS clones declined
along with the passage, and growth was halted in many
clones beyond 45 passages. Eventually, only one matched
pair (HPS-14 and HPS-15) and another cancer-associated
stromal clone (HPS-11) reached passage 60. It appeared
that these established clones represented stable primary
prostate stromal cell lines, which could be continuously
cultured for experimental use for less than 30 passages.
The HPS clones all showed low proliferation activity.
When examined for growth rate in sub-confluence, all the
clones showed even slower growth than the original LNCaP
prostate cancer cell line (Fig. 2A), which is known to have a
slow growth rate (Singh et al. 1999). Interestingly, we did
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not observe a differential proliferation in cancer-associated
stromal cells, since none of the cancer-associated stromal
clones grew faster than its normal counterpart.
Prostate stromal cells are insensitive to androgen depriva-
tion. Prostate stromal cells may have differentiated sensitivity
to androgens compared to prostate epithelial cells. As
androgen deprivation in vivo effectively causes programmed
death of the epithelial cells, it is less effective on the stromal
compartment (English et al. 1985; Sagalowsky 1985; Lippert
and Keefer 1987; McConnell 1990; Sensibar et al. 1990). To
assess whether the established HPS clones inherited the same
property, we cultured the cells in androgen deprivation
medium for 4 d and determined the growth rate. Compared
to the LNCaP cells whose growth was inhibited under these
conditions, the HPS clones grew well. No significant
changes in growth rate were detected in the treated cells
(Fig. 2A). In addition, we determined that growth of the
established stromal cells was not stimulated by the synthetic
androgen R1881 (Fig. 2B). It seemed that proliferation of the
Figure 1. Morphologic features
of the HPS cell clones. Phase
contrast microphotographs of
the matched pairs of HPS cells
are shown at ×100 magnifica-
tion. All photos were taken at
passage 6 of the cultures. The
normal human primary prostate
stromal cell line PrSC at passage
6 was used for comparison.
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established prostate stromal clones proceeded in an
androgen-independent fashion.
To determine the survival potential of the stromal cells,
we compared these cells with LNCaP prostate cancer cells
for their survival after serum starvation. Under these culture
conditions, stromal cells maintained the same morphology
for more than 4 wk. Subsequently, the cells became
narrower while some detached and were removed by
change of medium. The majority of the cells survived and
the stromal monolayer remained intact (Fig. 3A). In two
experiments, to maintain cells for 60 d under androgen-free
and serum-free conditions, all the stromal clones survived
the experiments. At the end of the 60-d treatment, the
vitality of the cells was confirmed by colony formation
assays, in which recovered cells formed substantial numb-
ers of colonies (Fig. 3B). In parallel experiments, the
androgen-dependent LNCaP prostate cancer cells failed to
survive serum starvation. Most died around 5 wk, and by
60 d, no LNCaP colonies were formed in two colony
formation experiments. Relative to LNCaP prostate cancer
cells, the established prostate stromal clones were highly
resistant to androgen deprivation and serum starvation.
In these studies, when matched normal and cancer-
associated stromal cells were compared for their survival
capability, two cancer-associated stromal clones (HPS-11
and HPS-15) formed significantly more colonies than their
respective normal counterparts (Fig. 3C). On the other
hand, the normal HPS-12 and cancer-associated HPS-13
stromal cells were found to have similar colony formation
in two separate experiments. In two of the three matched
pairs, cancer-associated prostate stromal clones appeared to
be more resistant to serum starvation than the normal
stromal cells.
Cancer-associated prostate stromal cells rescue LNCaP
prostate cancer cells from starvation-induced death. Stro-
mal cells of the tumor microenvironment may promote
cancer cell survival through mechanisms of cancer–stromal
interaction (Sung and Chung 2002; Kogan-Sakin et al.
2009). Since the prostate stromal clones were insensitive to
androgen and were highly resistant to serum starvation
(Figs. 2 and 3), we assessed whether the stromal clones
could promote survival of prostate cancer cells under
similar conditions. The study was conducted by co-
culturing the stromal cells with LNCaP prostate cancer
cells. To prepare for co-culture, stromal cells were first
grown to form a confluent monolayer completely covering
the plastic surface of the culture ware. After removal of the
culture medium, LNCaP prostate cancer cells were overlaid
onto the monolayer in low density, so the co-culture was
comprised of equal numbers of stromal and cancer cells.
Cells in the co-culture were treated with serum starvation
for 60 d. During the treatment, most of the LNCaP cells
died gradually, as seen by microscopic inspection and
detected by markedly reduced PSA in the culture medium
(Fig. 4A). The low PSA level, however, was sustained to
the end of the experiment at 60 d. Since none of the
prostate stromal clones expressed detectable levels of PSA
by ELISA (Fig. 4A and data not shown), these results
suggested that some LNCaP cells had survived the
starvation.
To confirm the survival of LNCaP cells, we included in
the experiment a red fluorescent LNCaP clone, RL-1,
which stably expressed an AsRed2 red fluorescence
protein. Similar to the parental LNCaP cells, the RL-1
clone was sensitive to serum starvation (Fig. 4A and B).
Figure 2. Androgen-independent growth of the HPS cell clones. A,
HPS cells were treated with androgen-deprivation for 96 h and
assayed for cell proliferation by crystal violet staining. B, HPS cells
were treated with synthetic androgen R1881 for 96 h and assayed for
cell proliferation. In these experiments, growth of the androgen-
dependent human LNCaP prostate cancer cells was used as a positive
control. Data represent the mean of a triplicate assay, and the results
are representative of two separate experiments. For each cell line, an
asterisk indicates statistical significance (p<0.05) compared to control
group of the cell line.
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The co-cultures were subjected to serum starvation for 60 d,
and survival of the RL-1 was documented by fluorescence
microscopy. Although the number of red fluorescent cells
became fewer as serum starvation progressed, these cells
never disappeared (Fig. 4C). Moreover, at the end of the
experiment when the mixed cells in co-culture were
replated in regular culture medium for colony formation, a
substantial number of red fluorescent colonies were formed
(Fig. 4D). These results were in contrast to the control
group, in which RL-1 cells alone were subjected to serum
starvation. Cells in the control group all perished around
35 d (Fig. 4B) and following the 60-d starvation, no red
fluorescent colonies were formed in colony formation
assays. This study indicated that by co-culture, prostate
stromal cells could rescue LNCaP cells from starvation-
induced death.
Compared to their normal counterparts, the cancer-
associated HPS-11 and HPS-15 stromal cells displayed
preferential protection to the LNCaP prostate cancer cells.
In colony formation assays, when survival of the cancer cells
was quantified following a 60-d serum starvation, 271.3±
57.1 red fluorescent colonies were formed from a triplicate
co-culture of RL-1 with cancer-associated HPS-11 stromal
cells, comparing to 61±11 colonies from the co-cultures with
the normal HPS-10 stromal cells (P<0.05). Similarly,
significantly more red fluorescent colonies were formed
from the co-culture with cancer-associated HPS-15 stromal
cells (613.3±187.7) than with the normal HPS-14 stromal
cells (81±18.5). The results from these studies indicated
that cancer-associated stromal cells showed stronger tro-
pism on survival of the LNCaP prostate cancer cells.
Discussion
In this work, we established three matched pairs of normal and
cancer-associated human prostate stromal cell lines. These cell
cultures represent a rare collection of cells that can be used to
explore cancer–stromal interaction. We describe the initial
characterization of these cell lines at the morphologic and
behavioral levels. By extracting common morphologic and
behavioral features in three matched pairs, this study may
provide a general view of the prostate stromal cells in culture.
This study demonstrates that prostate stromal cells are
androgen-insensitive and are highly resistant to serum starva-
tion (Figs. 2 and 3). This feature may be a reflection of the
prostate stromal cells in clinical cases and animal studies,
where androgen removal shows differentiated effects on
epithelial and stromal cells (English et al. 1985; Sagalowsky
1985; Lippert and Keefer 1987; McConnell 1990; Sensibar et
al. 1990). The cause of the androgen insensitivity and
starvation resistance is poorly defined. Since the results were
obtained from isolated stromal cells cultured in a defined
medium, this study may suggest that androgen independence
and starvation resistance are inherent properties of prostate
stromal cells, sustained by endogenous mechanisms. The
prostate stromal clones will be ideal subjects for investigating
the molecular mechanisms underlying these properties.
We determined that cancer-associated prostate stromal
cells have differential capabilities to survive serum starva-
tion, as two of the three cancer-associated stromal clones
formed significantly more colonies than the normal coun-
terparts (Fig. 3C). Moreover, the HPS-11 and HPS-15
cancer-associated stromal cells displayed increased potential
Figure 3. Prostate stromal cells are resistant to serum starvation. A,
Morphologies of a monolayer of HPS-15 cells at the beginning (Day 1)
and end (Day 60) of serum starvation. The starved cells became
narrower, attached by abundant extracellular matrix materials. B, after
60 d of serum starvation, surviving stromal cells were subjected to
colony formation for 2 wk. Two representative colonies are shown from
the surviving HPS-15 cells. C, Results of the colony formation by
surviving stromal cells after 60 d of serum starvation. Data represent the
mean of triplicate assays. For each matched pair, an asterisk indicates
statistical significance (p<0.05) compared to the counterpart.
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to rescue LNCaP cells from serum starvation. These results
are in agreement with the findings that cancer-associated
stromal cells in the tumor microenvironment may have
pathophysiologic behaviors (Ayala et al. 2003; Micke and
Ostman 2004). We are currently performing comparative
analyses on these matched stromal pairs in order to identify
expressional changes supporting these behaviors.
We found few dramatic differences between the normal
and cancer-associated prostate stromal cells as far as
morphology and proliferation are concerned. The matched
pairs showed mutually similar large shapes and slow
growth (Figs. 1 and 2). On the other hand, both the cellular
morphology and proliferation rate are quite distinct from
those of the prostate cancer cells (Fig. 4C and D). In the
study of cancer–stromal interaction, the distinction may
facilitate cell tracking during co-culture of cancer and
stromal cells. Together with the fluorescently labeled LNCaP
prostate cancer cells (Fig. 4B), these stromal cells are
valuable tools for in vitro investigation of cancer–stromal
interaction in prostate cancer progression and metastasis.
Figure 4. Stromal cells render LNCaP cells resistant to starvation-
induced death. Representative results from co-culture with the
HPS-15 stromal clone are shown. A, PSA production in the co-
cultures (LNCaP+HPS-15 and RL-1+HPS-15) was detected through-
out the serum starvation. In comparison, PSA was lost when cancer
cells alone (LNCaP and RL-1) were subjected to starvation. PSA is
not expressed in HPS-15 stromal cells (HPS-15). Data represent the
mean of triplicate assays. Standard deviation for each data is less
than 5% of the mean and is not shown. B, When RL-1 cells were
cultured alone, the loss of PSA production was due to cell death
under serum starvation. Shown are cultures of RL-1 alone at the
beginning (Day 1) and at Day 35 of serum starvation. All RL-1 cells
died after 35 d of serum starvation. For fluorescence photography, a
phase contrast microphotograph (upper panel) and red fluorescence
image (lower panel) of the same field are shown. C, Co-cultures of
RL-1 with HPS-15 at the beginning (Day 1) and end (Day 60) of
serum starvation. Representative surviving RL-1 cells (arrows) are
shown among stromal cells. D After a 60-d serum starvation,
surviving RL-1 cells from the co-culture formed colonies (arrows)
among stromal cell colonies upon replating in normal culture
medium for 14 d. Two representative results are shown.
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Using in vitro co-culture to simulate cancer–stromal
interaction, this study revealed that prostate stromal cells
could rescue LNCaP prostate cancer cells from serum
starvation (Fig. 4). Cultured alone, growth of the LNCaP
cells was reduced by androgen deprivation, and all the
LNCaP cells were killed by serum starvation (Fig. 4B). In
the presence of stromal cells, some cancer cells survived
and maintained a latent state for an extended time (Fig. 4C).
Under favorable conditions, these cells grew to form
colonies in large populations (Fig. 4D). This finding may
be clinically relevant because survival of cancer cells under
deprivation conditions may cause tumor latency and cancer
recurrence (Koivisto et al. 1996; Craft et al. 1999;
Thalmann et al. 2000; Tso et al. 2000; Schroder 2008). It
is likely that a key mechanism by which prostate stromal
cells facilitate cancer progression is to sustain the viability of
the cancer cells through cancer–stromal interaction. Further
investigation into the cancer–stromal interaction under
starvation conditions may unveil the molecular mechanism
mediating the effect. The established cancer–stromal co-
culture system described in this work is a simplified and
reproducible experimental model for such studies.
Conclusions
In this study, we isolated and characterized three matched
pairs of human prostate stromal clones. Compared to normal
counterparts, two of the three cancer-associated stromal
clones showed significantly higher resistance to serum
starvation and stronger protection of LNCaP prostate cancer
cells from starvation-induced death. The matched stromal
cell pairs may serve as models for comparative analysis of
molecular changes in the tumor microenvironment. These
cells can also be used in co-culture with prostate cancer cells
to simulate cancer–stromal interaction in the tumor micro-
environment in order to define the role of prostate stromal
cells in prostate cancer progression and metastasis.
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